HCPCS Level II · Outpatient PPS (temporary codes)
C9066Injection, sacituzumab govitecan-hziy, 2.5 mg
Terminated 12/31/2020
Source: CMS HCPCS quarterly update, October 2026. Page updated September 29, 2026.
About C9066
C9066 is an HCPCS Level II code in the C series (outpatient PPS (temporary codes)), describing injection, sacituzumab govitecan-hziy, 2.5 mg.
It was added to HCPCS effective 10/01/2020, and its current record took effect 01/01/2021.
It was terminated on 12/31/2020 and can't be billed for later dates of service.
Its Medicare coverage code is "D", meaning special Medicare coverage instructions apply.
Details
- Short description
- Sacituzumab govitecan-hziy
- Date added
- 10/01/2020
- Action effective
- 01/01/2021
- Termination date
- 12/31/2020
- BETOS
- O1D
Related C90xx codes
Common questions about C9066
Is HCPCS C9066 still valid?
- No. C9066 was terminated on 12/31/2020.
Does Medicare cover C9066?
- Its coverage code is "D": special Medicare coverage instructions apply. Check the local coverage determination for your region.